The relationship between pharmacokinetics and pharmacodynamic action as applied to in vivo pA2: application to the analgesic effect of morphine
- PMID: 660555
The relationship between pharmacokinetics and pharmacodynamic action as applied to in vivo pA2: application to the analgesic effect of morphine
Abstract
When the pA2 of an antagonist is determined in vivo, administered doses are used rather than the peak or steady-state tissue concentrations. The present report examines the error which can arise in this method and also presents a method for determining the pA2 from data obtained at times after peak. We applied this time-dependent analysis to time-dose-response data obtained with morphine-naloxone in the rat, using tail compression as the nociceptive stimulus. Good agreement between pA2 values was found: 8.0 with peak effect data, and 8.1 with the time-dependent method. Further, this analysis yielded 20 minutes as the half-life of naloxone. It is concluded that the time-dependent method provides a check on the pA2 in vivo and confirms the utility of this constant in classifying receptors. The appendix contains methodology for application to other agonist-antagonist combinations classified according to their kinetics.
Similar articles
-
Potency, duration of action and pA2 in man of intravenous naloxone measured by reversal of morphine-depressed respiration.J Pharmacol Exp Ther. 1981 Oct;219(1):156-62. J Pharmacol Exp Ther. 1981. PMID: 7288605 Clinical Trial.
-
In vivo antagonism by naloxone of morphine, beta-endorphin and a synthetic enkephalin analog.J Pharmacol Exp Ther. 1978 Dec;207(3):878-83. J Pharmacol Exp Ther. 1978. PMID: 731437
-
Alterations in the antagonism by naloxone of morphine-induced respiratory depression and analgesia after morphine pretreatment.J Pharmacol Exp Ther. 1978 Dec;207(3):884-91. J Pharmacol Exp Ther. 1978. PMID: 731438
-
Measuring naloxone antagonism of discriminative opioid stimulus.Fed Proc. 1982 May;41(7):2319-22. Fed Proc. 1982. PMID: 7042395 Review.
-
The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone.Clin Pharmacokinet. 1976;1(3):219-30. doi: 10.2165/00003088-197601030-00004. Clin Pharmacokinet. 1976. PMID: 13957 Review.
Cited by
-
Quantitative pharmacological analyses of the interaction between flumazenil and midazolam in monkeys discriminating midazolam: Determination of the functional half life of flumazenil.Eur J Pharmacol. 2014 Jan 15;723:405-9. doi: 10.1016/j.ejphar.2013.10.065. Epub 2013 Nov 8. Eur J Pharmacol. 2014. PMID: 24216249 Free PMC article.
-
Associative factors in the effects of morphine on self-stimulation.Psychopharmacology (Berl). 1986;88(4):472-9. doi: 10.1007/BF00178509. Psychopharmacology (Berl). 1986. PMID: 3085135
-
Dose-dependent naloxone-induced morphine withdrawal symptoms in opioid-dependent males-a double-blinded, randomized study.Br J Clin Pharmacol. 2020 Aug;86(8):1610-1619. doi: 10.1111/bcp.14271. Epub 2020 Mar 20. Br J Clin Pharmacol. 2020. PMID: 32145041 Free PMC article. Clinical Trial.
-
Supersensitivity to opioids following the chronic blockade of endorphin action by naloxone.Naunyn Schmiedebergs Arch Pharmacol. 1979 Jan;306(1):93-6. doi: 10.1007/BF00515600. Naunyn Schmiedebergs Arch Pharmacol. 1979. PMID: 424002
-
Effects of opiate antagonists on hormones and behavior of male and female rhesus monkeys.Arch Sex Behav. 1984 Feb;13(1):1-25. doi: 10.1007/BF01542974. Arch Sex Behav. 1984. PMID: 6424632